Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
The beta-lactamases from 403 Moraxella (Branhamella) catarrhalis clinical isolates obtained during 1994-1995 and 1997-1998 U.S. multicenter surveillance studies were characterized by isoelectric focusing. The overall prevalences of the BRO-1 and BRO-2 enzymes among beta-lactamase-positive isolates w...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2000
|
| _version_ | 1797102348080775168 |
|---|---|
| author | Richter, S Winokur, P Brueggemann, A Huynh, H Rhomberg, P Wingert, E Doern, G |
| author_facet | Richter, S Winokur, P Brueggemann, A Huynh, H Rhomberg, P Wingert, E Doern, G |
| author_sort | Richter, S |
| collection | OXFORD |
| description | The beta-lactamases from 403 Moraxella (Branhamella) catarrhalis clinical isolates obtained during 1994-1995 and 1997-1998 U.S. multicenter surveillance studies were characterized by isoelectric focusing. The overall prevalences of the BRO-1 and BRO-2 enzymes among beta-lactamase-positive isolates were estimated to be 97.5 and 2.5%, respectively. The minimum inhibitory concentrations (MICs) of ampicillin for all BRO-2-producing isolates were |
| first_indexed | 2024-03-07T06:04:43Z |
| format | Journal article |
| id | oxford-uuid:ed6f9c49-47ee-40c2-a60b-5cfa10712540 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:04:43Z |
| publishDate | 2000 |
| record_format | dspace |
| spelling | oxford-uuid:ed6f9c49-47ee-40c2-a60b-5cfa107125402022-03-27T11:25:01ZMolecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ed6f9c49-47ee-40c2-a60b-5cfa10712540EnglishSymplectic Elements at Oxford2000Richter, SWinokur, PBrueggemann, AHuynh, HRhomberg, PWingert, EDoern, GThe beta-lactamases from 403 Moraxella (Branhamella) catarrhalis clinical isolates obtained during 1994-1995 and 1997-1998 U.S. multicenter surveillance studies were characterized by isoelectric focusing. The overall prevalences of the BRO-1 and BRO-2 enzymes among beta-lactamase-positive isolates were estimated to be 97.5 and 2.5%, respectively. The minimum inhibitory concentrations (MICs) of ampicillin for all BRO-2-producing isolates were |
| spellingShingle | Richter, S Winokur, P Brueggemann, A Huynh, H Rhomberg, P Wingert, E Doern, G Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title | Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title_full | Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title_fullStr | Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title_full_unstemmed | Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title_short | Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. |
| title_sort | molecular characterization of the beta lactamases from clinical isolates of moraxella branhamella catarrhalis obtained from 24 u s medical centers during 1994 1995 and 1997 1998 |
| work_keys_str_mv | AT richters molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT winokurp molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT brueggemanna molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT huynhh molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT rhombergp molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT wingerte molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 AT doerng molecularcharacterizationofthebetalactamasesfromclinicalisolatesofmoraxellabranhamellacatarrhalisobtainedfrom24usmedicalcentersduring19941995and19971998 |